BiVACOR key facts
- Developer of an artificial heart-pumping device designed to take over the complete function of a patient's failing heart.
- BiVACOR’s last known valuation is $109.0M.
- It has raised $60.4M across 1 recorded rounds; the latest was Early Stage VC ($9.0M) in Jul 2024.
- Notable investors include National Institutes of Health, Texas Medical Center, Cormorant Asset Management, OneVentures, Advance Queensland — 18 tracked in total.
- BiVACOR has filed 1 Form D with the SEC, most recently Aug 2024 ($9.0M sold to 3 investors).
- Status: Privately Held (backing).
Who backs BiVACOR
18+- ·The complete investor list: 18 names
- ·Watch BiVACOR: the Monday email on marks, rounds and moves
BiVACOR funding rounds
1 roundsBiVACOR valuation
BiVACOR's last known valuation is $109 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has BiVACOR raised?
BiVACOR has raised $60.4 million in total; 1 of its rounds is on record. The largest on record was a $9 million early-stage round in Jul 2024.
BiVACOR has filed 1 Form D with the SEC, most recently in Aug 2024 ($9 million sold to 3 investors).
BiVACOR investors
18 investors are on record for BiVACOR, including National Institutes of Health, Texas Medical Center, Cormorant Asset Management and OneVentures. The early-stage round in Jul 2024 drew 3 investors.
About BiVACOR
Developer of an artificial heart-pumping device designed to take over the complete function of a patient's failing heart. The company's compact device comprises a magnetically levitated rotor between opposing pump casings and leverages rotary blood pump technology to provide the required cardiac output, enabling patients to reduce the risk of blood-cell damage and clotting and survive with a substitute blood pumping system.
- Sector
- Healthcare
- HQ
- Huntington Beach, CA, United States
- Founded
- 2008
- Employees
- 47
- Website
- bivacor.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
BiVACOR’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.